TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big December 2, 2011